From: CRISPR-Cas gene editing technology and its application prospect in medicinal plants
Engineered Cas9 variants | Included mutations | PAM (5′ to 3′) | Notes | Refs. |
---|---|---|---|---|
SpCas9 VRER | D1135V, G1218R, R1335E, T1337R of SpCas9 mutations | NGCG | Altered PAM variant; Bacterial-selection-based screening | |
SpCas9 VQR | D1135V, R1335Q, T1337R of SpCas9 mutations | NGAN or NGNG | Altered PAM variant; Bacterial-selection-based screening | |
SpCas9 EQR | D1135E, R1335Q, T1337R of SpCas9 mutations | NGAG | Altered PAM variant; Bacterial-selection-based screening | [61] |
SpCas9-NG | R1335V, L1111R, D1135V, G1218R, E1219F, A1322R, T1337R of SpCas9 mutations | NG | Altered PAM variant | [62] |
SpG | D1135L, S1136W, G1218K, E1219Q, R1335Q, T1337R of SpCas9 mutations | NGN | A near-PAMless variant | |
SpRY | A61R, L1111R, N1317R, A1322R, R1333P introduced into SpG | NRN, NYN | A near-PAMless variant | |
xCas9 3.7 | E480K, E543D, E1219V, A262T, R324L, S409I, M694I of SpCas9 mutations | NG, GAA, GAT | Expanded PAM recognition range; Phage-assisted continuous evolution (PACE) | |
SpCas9-HF1 | N497A, R661A, Q695A, Q926A of SpCas9 mutations | NGG | Enhanced specificity | [64] |
eSpCas9 (1.0) | K810A, K1003A, R1060A of SpCas9 mutations | NGG | Enhanced specificity; Structure-guided protein engineering | [65] |
eSpCas9 (1.1) | K848A, K1003A, R1060A of SpCas9 mutations | NGG | Enhanced specificity; Structure-guided protein engineering | |
evoCas9 | M495V, Y515N, K526E, R661Q of SpCas9 mutations | NGG | Enhanced specificity; Yeast-based screening | [42] |
HypaCas9 | N692A, M694A, Q695A, H698A of SpCas9 mutations | NGG | Enhanced specificity | [67] |
HiFi Cas9 | single point mutation R691A of SpCas9 | NGG | Enhanced specificity for ribonucleoprotein delivery | [68] |
KKH SaCas9 | E782K, N968K, R1015H of SaCas9 mutations | NNNRRT | Altered PAM variant | |
SaCas-HF | R245A, N413A, N419A, R654A of SaCas9 mutations | NNGRRT | Enhanced specificity and genome-wide targeting accuracy | |
efSaCas9 | single point mutation N260D of SaCas9 variant Mut268 | NNGRRT | Enhanced specificity; Human cells-based screening | |
(HiFi-)Sc++ | Thr1227Lys, Arg701Ala mutations and loop sequence from S. anginosus introduced into ScCas9 | NNG | Enhanced specificity and activity |